David J. Gury
Director/Miembro de la Junta en Scripps Florida Funding Corp. .
Cargos activos de David J. Gury
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Gury Consulting LLC | Corporate Officer/Principal | 01/06/2004 | - |
Scripps Florida Funding Corp. | Director/Miembro de la Junta | 01/04/2005 | - |
Florida Atlantic University Foundation, Inc. | Treasurer | - | - |
Historial de carrera de David J. Gury
Antiguos cargos conocidos de David J. Gury.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
U.S. STEM CELL, INC. | Director/Miembro de la Junta | 01/07/2005 | 07/01/2009 |
ORAGENICS, INC. | Presidente | 01/10/2003 | 08/04/2008 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Presidente | 01/05/1984 | 01/05/2004 |
Presidente | 01/05/1984 | 01/05/2004 | |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Presidente | - | - |
Formación de David J. Gury.
Kenyon College | Undergraduate Degree |
The University of Chicago | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 10 |
Operativa
Chairman | 3 |
Director/Board Member | 2 |
President | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ORAGENICS, INC. | Health Technology |
U.S. STEM CELL, INC. | Health Services |
Empresas privadas | 5 |
---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
Gury Consulting LLC | |
Scripps Florida Funding Corp. | |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Commercial Services |
Florida Atlantic University Foundation, Inc. |
- Bolsa de valores
- Insiders
- David J. Gury
- Experiencia